Home / Stocks / RNAC

RNAC insider trading

Cartesian Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$16.1M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-08

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-08BARABE TIMOTHY C
Director
Bought30,000$6.86$206k
2025-04-11SPRINGER TIMOTHY A
Director · 10% owner
Bought149,075$10.21$1.5M
2025-03-20SPRINGER TIMOTHY A
Director · 10% owner
Bought89,863$15.26$1.4M
2025-01-15SPRINGER TIMOTHY A
Director · 10% owner
Bought20,967$17.47$366k
2024-12-23SPRINGER TIMOTHY A
Director · 10% owner
Bought52,189$18.49$965k
2024-11-18SPRINGER TIMOTHY A
Director · 10% owner
Bought431,940$17.07$7.4M
2024-10-04SPRINGER TIMOTHY A
Director · 10% owner
Bought205,721$20.87$4.3M

Most active insider buyers

InsiderRoleBuysTotal bought
SPRINGER TIMOTHY ADirector · 10% owner6$15.9M
BARABE TIMOTHY CDirector1$206k

See RNAC on the chart

Every insider buy and sell for RNAC plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.